Please cite this article in press Osama Uddin et al., Advances In Liposphere Technology For The Delivery Of BCS CLASS II Drugs: A Review.,Indo Am. J. P. Sci, 2024; 11 (10).

1. Dixit N, Gupta A, Asija R, Sharma M. Liposphere: a Noval Approach of Drug Delivery. World Journal of Pharmaceutical and Medical Research. 2017; 3(6):124-30.
2. Motawee AO, Khafagy E, Gardouh AR, Ghourab MM. Lipospheres and Pro-Nanolipospheres: Advancements in Drug Delivery Systems. Records of Pharmaceutical and Biomedical Sciences. 2023 Jan 1; 7(3):41-50.
3. Rathor M, Gupta MK, Sharma V.A review on oral liposphere of candesartan cilexetil.Int J Pharma Bio Sci Archive, 2018;6(1):01-04.
4. Hassan-Alin M, Andersson T, Bredgerg E, Rohss K: Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Eur J Clin Pharmacol 2000; 56: 665–670.
5. Swan SK, Hoyumpa AM, Merritt GJ: Review article: The pharmacokinetics of rabeprazole in health and disease. Aliment Pharmacol Ther 1999; 13:11–17.
6. Muhrer G, Meier U, Fusaro F, Albano S, Mazzotti M. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water soluble drug: Generation of drug microparticles and drugpolymer solid dispersions. Int J Pharm 2006; 308:69-80
7. Balakrishna T, Vidyadhara S, Sasidhar RL, Prasanna PS, Murthy TE. Formulation and evalution of lansoprazole orodispersable tablets.International Journal of Pharmaceutical Sciences and Research.2017 Feb 1; 8(2):804.
8. Mehta S, Joseph NM, Feleke F, Palani S. Improving solubility of BCS class II drugs using solid dispersion: a review. Journal of drug delivery and therapeutics. 2014 May 15; 4(3):7-13.
9. Singh, M. K., Kumar, A., Kumar, R., Kumar, P. S., Selvakumar, P., & Chourasia, A. Effects of Repeated Deep Frying on Refractive Index and Peroxide Value of Selected Vegetable Oils. International Journal for Research in Applied Sciences and Biotechnology, 2022; 9(3), 28-31.
10. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005; 22:11–23.
11. Blagden, N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev. 2007; 59:617–630.
12. He CX, He ZG, Gao JQ. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs. Expert Opin on Drug Deliv. 2010a; 7:445–60.
13. Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, Yamada S. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci. 2010b; 99:1871–81.
14. Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm and Biopharm.2000; 50:3–12.
15. Oberle RX, Amidon GL. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon. J Pharmacokinet Biopharm.1987; 15:529–44.
16. Yu LX.An integrated absorption model for determining dissolution, permeability, and solubility limited absorption. Pharm Res. 1999; 16:1884–8.
17. Singh N, Allawadi D, Singh S, Arora S. Techniques for bioavailability enhancement of BCS class II drugs: a review. International Journal of Pharmaceutical and Chemical Sciences. 2013; 2(2):1092-101.
18. Ahuja N, Katare OP, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. European Journal of Pharmaceutics and Biopharmaceutics.2007 Jan 1;65(1):26-38.
19. Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods and findings in experimental and clinical pharmacology. 1998 Apr 1; 20(3):211-5.
20. Babu VR, Areefulla SH, Mallikarjun V. Solubility and dissolution enhancement: an overview. J Pharm Res. 2010 Jan; 3(1):141-5.
21. Bakatselou V, Oppenheim RC, Dressman JB. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharmaceutical research.1991 Dec; 8:1461-9.
22. Challa R, Ahuja A, Ali J, Khar R. Cyclodextrins in drug delivery: an updated review. Aaps Pharmscitech. 2005 Jun;6: E329-57.
23. Talari R, Nokhodchi A, Mostafavi SA, Varshosaz J. Dissolution enhancement of gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties. Journal of Pharmacy & Pharmaceutical Sciences. 2009 Sep 30; 12(3):250-65.
24. Bertucco, A., Vetter, G. High Pressure Process Technology: Fundamentals and Applications. Industrial Chemistry Library, Elsevier, Amsterdam. 2001: 9, 1-3.
25. Chowdary KP, Madhavi BL. Novel drug delivery technologies for insoluble drugs.Indian drugs-bombay. 2005; 42(9):557.
26. Mangenheim B., Levy M.Y., Benita S. An in vitro technique for evaluation of drug release profile from colloidal carriers – ultrafiltration technique at low pressure.Int. J. Pharm., 1993; 94: 115–120.
27. Manogna Katta., Sagar S. Vanitha. A detailed review on lipid based carrier drug delivery system: lipospheres. International Journal of Scientific Research. 2019 July; 8(7): 39-42.
28. Satheeshbabu N, Gowthamarajan K. Manufacturing techniques of lipospheres: overview. International Journal of Pharmacy and Pharmaceutical Sciences.2011; 3(4):17-21.
29. Amselem A, et.al. Emulsions, a novel drug delivery technology.Proc Int Symp Control Rel Mater Bioacts.1994; 2: 668–69.
30. Salome A, Ikechukwu V. Lipid based drug delivery systems (LDDS): Recent advances and applications of lipids in drug delivery. African Journal of Pharmacy and Pharmacology, 2012; 7(48): 3034-59.
31. Sirisha CH, Chaitanya B, Naganathan L, Sharma JV. An overview on lipospheres. World Journal of Pharmaceutical Sciences.2020 Jan 2:6-12.
32. Wattamwar MM, Ratnaparkhi Mukesh P, Chaudhari Shilpa P. Liposphered lipid based drug delivery system: a review. Asian J Pharm Technol Innovation.2014; 2(06).
33. Natarajan, S., Lakshmanan, P., Nerkar, N., Bajaj, A., Shrikhande, S., & Jain, D. Effect of Processing Variables on Characterization of Ofloxacin Loaded Lipospheres Prepared by Melt Dispersion Technique. Current Drug Delivery, 2013; 10(5), 517–526.
34. Yalavarthi, P., Dudala, T., Mudumala, N., Pasupati, V., Thanniru, J., Vadlamudi, H., & Yaga, G.A perspective overview on lipospheres as lipid carrier systems. International Journal of Pharmaceutical Investigation, 2014; 4(4), 149.
35. Anzar FN, Mathan S, Dharan SS. Lipospheres. Journal of Pharmaceutical Sciences and Research. 2020 Oct 1; 12(10):1357-9.
36. Morel S, Gasco MR, Cavalli R.Incorporation in lipospheres of [D-Trp-6] LHRH.International journal of pharmaceutics.1994 May 2; 105(2):R1-3.
37. Rawat M., Saraf S. Liposphere: Emerging carriers in delivery of proteins and peptides. Int.J.Pharm.Sci. and Nanotechnol, 2008; 1: 207 – 214.
38. Ahirwar Ramesh, Mr. Chaurasia Ashish, Dr. Nigam Vijay, Dr. Chourasiya kumar Anil, Kankane Muskan, Adhikari Pooja. Liposphere: A Comprehensive Review. International Journal of Pharmaceutical Research and Applications, 2023; 8(1): pp 1151-1161.
39. Domb AJ, Bergelson L, Amselem AS.Lipospheres for controlled delivery of substances. Microencapsulation: Methods and Industrial Applications.2005 Nov 1; 297.
40. Nastruzzi C. Lipospheres in drug targets and delivery: approaches, methods, and applications. CRC Press; 2004 Nov 29.
41. Morel S., Ugazio E., Cavalli R., Gasco M.R. Thymopentin in solid lipid nanoparticles: Int. J. Pharm., 1996; 132: 259–261.
42. Leeladhar Prajapati, lipospheres: recent advances in various drug delivery system,International Journal Of Pharmacy & Technology; 2013,5 (1),2446-2464.
43. Dudala TB, Yalavarthi PR, Pasupati VK.A Perspective overview on lipospheres.Int J Pharma Investig.2014; 4(4):149-55.
44. Gander B, johansen P, Nam-Tran H, Merkle HP.Thermodynamic approach to protein microencapsulation into poly (D,L-lactide) by spray drying.Int J Pharm 1996; 129:51-61.
45. Attama AA, Okafor CE, Builders PF, Okorie O. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. Drug delivery. 2009 Nov 1;16(8):448-57.
46. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 2006; 29(3-4): 278-87.
47. Nancy Dixit, et.al. Liposphere: A novel approach of drug delivery, World Journal of Pharmaceutical and Medical Research, 2017; 3(6):124-130.
48. Bhosale UM, Galgatte UC, Chaudhari PD. Development of pioglitazone hydrochloride lipospheres by melt dispersion technique: Optimization and evaluation. Journal of Applied Pharmaceutical Science. 2016 Jan 26; 6(1):107-17.
49. Momoh MA, Kenechukwu FC, Gwarzo MS, Builders PF. Formulation and evaluation of ibuprofen loaded lipospheres for effective oral drug delivery. Dhaka University Journal of Pharmaceutical Sciences. 2015 Jun 18; 14(1):17-27.
50. Rasul A, Maheen S, Khan HU, Rasool M, Shah S, Abbas G, Afzal K, Tariq F, Shahzadi I, Asad MH.Formulation, Optimization, In Vitro and In Vivo Evaluation of Saxagliptin‐Loaded Lipospheres for an Improved Pharmacokinetic Behavior. BioMed Research International.2021; 2021(1):3849093.
51. Galgatte UC, Bhosale UM, Chaudhari PD. Formulation development, optimization and in-vitro evaluation of glimepiride lipospheres. Int. J.Pharm. Sci. Rev.Res.2015; 34:157-62.
52. Patil M, Sonawane D, Sonawane S, Bhambere D, Kshirsagar S. Application of Central Composite Design for Development of Celecoxib Loaded Lipospheres: Formulation and in-vitro Characterization. Indian journal of pharmaceutical education and research.2020 Apr 1; 56(2):405-13.